FMI Research Offers 10-Year Forecast on Depression And | Page 4

Depression And Seasonal Affective Disorder Therapeutics Market
Depression And Seasonal Affective Disorder Therapeutics Market Size, Analysis, and Forecast Report
2017-2027
Seasonal Affective Disorder is also referred as winter depression though it comes and goes in the winter
season. The symptoms of the seasonal affective disorder often begin in autumn, when the days are
getting shorter. This disorder mostly occurs in the month of December, January, and February. This
disorder improves and disappears as spring and summer start. Seasonal affective disorder frequently
happens due to reducing light exposure to sunlight during winter. The lack of sunlight might result
improper working of the hypothalamus which may affect the production of melatonin and serotonin and
also affects body’s internal clock. The symptoms of season affective disorder are persistent loss of mood,
irritability, loss of pleasure in doing everyday activities, feeling lethargic and sleepy during day. The
seasonal affective disorder can be treated by three methods, psychological treatment, light therapy and
medication. In psychological treatment, cognitive behavioral therapy (CBT) and counseling are provided
to the patient while light therapy can be done by two types: bright light treatment and dawn simulation.
Medication treatment is done by prescribing the antidepressant such as SSRIs. The intake of SSRIs can
lead
to
some
side
effect
such
as
anxious,
upset
stomach
and
diarrhea.
Depression and Seasonal Affective Disorder Therapeutics Market: Drivers and Restraints
The major driving factors for depression and seasonal affective disorder therapeutics market is the rise in
geriatric population and change in lifestyle of people. The technological development tends to
©2015 Future Market Insights, All Rights Reserved
4